Ignite Creation Date:
2025-12-24 @ 7:52 PM
Ignite Modification Date:
2025-12-29 @ 9:51 PM
Study NCT ID:
NCT01291004
Status:
COMPLETED
Last Update Posted:
2021-12-08
First Post:
2011-02-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives
Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-01-31
Start Date Type:
ACTUAL
Primary Completion Date:
2012-03-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-03-31
Completion Date Type:
ACTUAL
First Submit Date:
2011-02-04
First Submit QC Date:
None
Study First Post Date:
2011-02-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-12-01
Last Update Post Date:
2021-12-08
Last Update Post Date Type:
ACTUAL